IP Verse

Cohausz & Florack vs. Celltrion - APP_61187/2024

The UPC Case APP_61187/2024 was filed on 14 Nov, 2024 by the plaintiff Cohausz & Florack against the defendant Celltrion, Genentech, Novartis.

Case Details

    Case Number:

    APP_61187/2024

    Patent Number:

    EP3805248

    Filing Date:

    14 Nov, 2024

    Proceeding Type:

    Generic

    Case Phase:

    Case Closed

    Plaintiffs:

    • Cohausz & Florack

    Plaintiff Representatives:

    • Natalie KIRCHHOFER

    Defendants:

    • Celltrion
    • Genentech
    • Novartis

    Defendant Representatives:

    • Kilian SEIDEL

    Judges:

    • Alima Zana
    • Berenice Thom
    • John Petersen
    • Ronny Thomas

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-
Jan 6, 2025Receipt-
Jan 3, 2025Statement To The Application Under R.262.1 (B) Rop Upc-
Jan 3, 2025Statement To The Application-
Jan 3, 2025Set Of Exhibits Fbd 49 (Conf)-
Jan 3, 2025Request For Confidentiality-
Jan 3, 2025Exhibit Fbd 48 (Conf)-
Jan 3, 2025Exhibit Fbd 47 (Conf)-
Jan 3, 2025Exhibit Fbd 47-
Dec 27, 2024241227 Brief Celltrion Signed-
Dec 6, 2024Order Opportunity To Comment-
Nov 14, 2024241245Ep Up V01 Cf Access To File Request Signed-

More cases involving EP3805248B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands, Genentech, Novartis
ACT_18492/2024Apr 9, 2024Genentech, NovartisCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands
ACT_18551/2024Apr 9, 2024Genentech, NovartisCelltrion

More cases involving Cohausz & Florack

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands, Genentech, Novartis

More cases involving Celltrion

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_61203/2024Nov 14, 2024Cohausz & FlorackCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands
ORD_43328/2024Jul 24, 2024Genentech, NovartisCelltrion Healthcare Belgium, Celltrion Healthcare Deutschland, Celltrion Healthcare Finland, Celltrion Healthcare France, Celltrion Healthcare Hungary KFT, Celltrion Healthcare Italy, Celltrion Healthcare Netherlands
ORD_43329/2024Jul 24, 2024Genentech, NovartisCelltrion